Zobrazeno 1 - 10
of 49
pro vyhledávání: '"B D, Minsky"'
Autor:
B. D. Minsky
Publikováno v:
Diseases of the Esophagus. 9:86-89
Autor:
Nicola Nicolotti, Francesco Cellini, Giuseppe La Torre, Elisa D'Angelo, B. D. Minsky, Mario Balducci, Vincenzo Valentini, Nicola Dinapoli, Chiara Valentini, Giuseppe D'Agostino, Gian Carlo Mattiucci
Background and purpose A systematic review and meta-analysis was performed to assess the impact of radiotherapy on both 3- and 5-year survival in patients with resectable gastric cancer. Methods Randomized Clinical Trials (RCTs) in which radiotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1bff67424714d23897224dc62217f25
http://hdl.handle.net/10807/28441
http://hdl.handle.net/10807/28441
Autor:
Margaret A. Tempero, Rob Glynne-Jones, C.J.H. van de Velde, Malcolm A.S. Moore, H.-J. Schmoll, Josep Tabernero, David Cunningham, Michel Ducreux, Ph. Rougier, Bernard Nordlinger, David J. Kerr, A. de Gramont, Richard M. Goldberg, Y-K Kang, Karin Haustermans, N. Arber, Mario Dicato, Roberto Labianca, B. D. Minsky, John Zalcberg, J.-F. Bosset, Alberto Sobrero, Daniel G. Haller, E. Van Cutsem, Eduardo Díaz-Rubio, Werner Scheithauer
Publikováno v:
Annals of Oncology
Annals of Oncology, Oxford University Press (OUP), 2008, 19 Suppl 6, pp.vi1-vi8. 〈10.1093/annonc/mdn358〉
Annals of Oncology, Elsevier, 2008, 19 Suppl 6, pp.vi1-vi8. ⟨10.1093/annonc/mdn358⟩
Annals of Oncology, Oxford University Press (OUP), 2008, 19 Suppl 6, pp.vi1-vi8. 〈10.1093/annonc/mdn358〉
Annals of Oncology, Elsevier, 2008, 19 Suppl 6, pp.vi1-vi8. ⟨10.1093/annonc/mdn358⟩
International audience; Knowledge of the biology and management of rectal cancer continues to improve. A multidisciplinary approach to a patient with rectal cancer by an experienced expert team is mandatory, to assure optimal diagnosis and staging, s
Autor:
B D, Minsky
Publikováno v:
Annali italiani di chirurgia. 72(5)
Combined modality therapy is an effective adjuvant therapy for many patients with clinically resectable rectal cancer. The indications for adjuvant therapy for rectal cancer are based on the pattern of failure after surgery. Despite radical surgery,
Autor:
R T, Wagman, B D, Minsky
Publikováno v:
Oncology (Williston Park, N.Y.). 15(4)
The standard surgical treatment of distal, resectable, invasive rectal cancers is an abdominoperineal resection or a low anterior resection. Given the morbidity associated with these standard treatments and the frequent need for postoperative adjuvan
Autor:
B D, Minsky
Publikováno v:
International journal of cancer. 96(1)
5-fluorouracil (5-FU) has become the most commonly used drug in combination with radiation therapy. The recent availability of oral formulations of 5-FU in conjunction with the ability to modulate the anabolic and catabolic metabolism of 5-FU with le
Autor:
B D, Minsky
Publikováno v:
Oncology (Williston Park, N.Y.). 12(8)
During the past decade, advances have been made in the adjuvant treatment of resectable rectal cancer. Postoperative combined-modality therapy significantly improves local control and survival. Recent Inter-group postoperative trials have focused on
Publikováno v:
The Lancet. 376:331-332
Publikováno v:
Oncology (Williston Park, N.Y.). 14(10 Suppl 9)
Postoperative combined-modality therapy with fluorouracil (5-FU) and radiation therapy is accepted practice for high-risk rectal cancer. Postoperative pelvic radiotherapy alone may improve pelvic control, but is not associated with an improvement in
Autor:
J E, Tepper, J L, Bader, N A, Janjan, B D, Minsky, L R, Coia, M J, John, G S, Merrick, D, Raben, T A, Rich, S A, Rosenthal, D, Ota, L, Saltz, S, Leibel
Publikováno v:
Radiology.